News & Updates

SOF/VEL combo improves well-being of children with CHC

27 Apr 2025 by

In children with chronic hepatitis C (CHC), effective treatment with sofosbuvir/velpatasvir (SOF/VEL) results in improvements in certain areas of their well-being at 1 year. This suggests some patient-reported outcomes (PRO) benefits of direct-acting antiviral (DAA) therapy. However, the parents’ proxy reports show a decrease in the patients’ school functioning.

SOF/VEL combo improves well-being of children with CHC

27 Apr 2025

Individualized treatment in febrile UTI helps reduce antibiotic exposure, related harms

27 Apr 2025

In the treatment of children with febrile urinary tract infection (UTI), individualized treatment appears to be associated with reduced antibiotic use and fewer adverse event days as compared with standard 10-day treatment, according to a study.

Individualized treatment in febrile UTI helps reduce antibiotic exposure, related harms

27 Apr 2025

Nirsevimab reduces RSV-related outcomes in infants

25 Apr 2025

Immunoprophylaxis with nirsevimab results in a 74-percent decrease in hospitalization and 85-percent reduction in paediatric intensive care unit (PICU) admissions due to respiratory syncytial virus (RSV)-related bronchiolitis, a study has shown.

Nirsevimab reduces RSV-related outcomes in infants

25 Apr 2025

MRSA infection may be detrimental to children with cystic fibrosis

25 Apr 2025

Among children with cystic fibrosis, those who contract methicillin-resistant Staphylococcus aureus (MRSA) infection appear to have worse respiratory outcomes, including increased antibiotic exposure and breathing obstruction, as reported in a retrospective study.

MRSA infection may be detrimental to children with cystic fibrosis

25 Apr 2025

Psychosocial stress linked to puberty timing

24 Apr 2025

Chronic psychosocial stress (PS) appears to contribute to the delayed onset of pubertal signs in children, suggests a recent study.

Psychosocial stress linked to puberty timing

24 Apr 2025

Fremanezumab helps prevent episodic migraine in youths

21 Apr 2025 by

The use of fremanezumab is safe and effective for the prevention of episodic migraine (EM) in children and adolescents as young as 6 years old, according to a study presented at AAN 2025.

Fremanezumab helps prevent episodic migraine in youths

21 Apr 2025

Maternal fat intake at pregnancy tied to higher offspring weight

15 Apr 2025

Pregnant women with increased fat intake, particularly trans fat, are more likely to deliver offspring with a higher body weight, suggests a study. Consumption of other macronutrients from various food sources, however, does not appear to affect offspring weight.

Maternal fat intake at pregnancy tied to higher offspring weight

15 Apr 2025

Gradual adalimumab tapering minimizes uveitis recurrence in children

15 Apr 2025

In children with noninfectious uveitis being treated with adalimumab, tapering speed appears to affect the risk of relapse, with a slow, gradual approach emerging as the optimal strategy, according to a multicentre retrospective cohort study.

Gradual adalimumab tapering minimizes uveitis recurrence in children

15 Apr 2025

Low serum ferritin associated with attention impairment in adolescents

14 Apr 2025 by

Low serum ferritin concentrations are associated with impairment in sustained attention among adolescents 16–19 years of age in Hong Kong, researchers from the Chinese University of Hong Kong (CUHK) have reported.

Low serum ferritin associated with attention impairment in adolescents

14 Apr 2025

Hepatitis A vaccine may be safely administered to children on biologic therapy

11 Apr 2025

Paediatric patients with autoinflammatory diseases undergoing treatment with canakinumab and tocilizumab can be safely vaccinated against hepatitis A, according to a prospective interventional study.

Hepatitis A vaccine may be safely administered to children on biologic therapy

11 Apr 2025

News & Updates

Filter by Specialty:

Specialty:

SOF/VEL combo improves well-being of children with CHC

SOF/VEL combo improves well-being of children with CHC

Individualized treatment in febrile UTI helps reduce antibiotic exposure, related harms

Individualized treatment in febrile UTI helps reduce antibiotic exposure, related harms

Nirsevimab reduces RSV-related outcomes in infants

Nirsevimab reduces RSV-related outcomes in infants

MRSA infection may be detrimental to children with cystic fibrosis

MRSA infection may be detrimental to children with cystic fibrosis

Psychosocial stress linked to puberty timing

Psychosocial stress linked to puberty timing

Fremanezumab helps prevent episodic migraine in youths

Fremanezumab helps prevent episodic migraine in youths

Maternal fat intake at pregnancy tied to higher offspring weight

Maternal fat intake at pregnancy tied to higher offspring weight

Gradual adalimumab tapering minimizes uveitis recurrence in children

Gradual adalimumab tapering minimizes uveitis recurrence in children

Low serum ferritin associated with attention impairment in adolescents

Low serum ferritin associated with attention impairment in adolescents

Hepatitis A vaccine may be safely administered to children on biologic therapy

Hepatitis A vaccine may be safely administered to children on biologic therapy